June 28, 2016: It’s official—FORUM Pharma will be shuttering its doors this week before the Fourth of July holiday. The company had been hammered by two major failed trials. In September 2015, the FDA advised the company to halt its clinical trials of encenicline for Alzheimer’s disease.
June 28, 2016: Infinity Pharma announced today that AbbVie chose to terminate its collaboration deal to develop and commercialize duvelisib. Duvelisib is a dual inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma.
June 28, 2016: Mayne Pharma announced it will be acquiring 37 approved drugs and five products that have been filed with the FDA from Teva and Allergan.
June 28, 2016: Veristat, a CRO based in Southborough, MA, is opening an office in the Research Triangle Park, NC area. As part of those plans, it expects to hire 150 or more local people.